Table 1.
Characteristic | Control (n=1,024) |
30DRA (n=123) |
P-Value |
---|---|---|---|
Age (years) | 51±14 | 52±14 | 0.880 |
Female Gender | 40% | 43% | 0.609 |
African-American Recipient | 53% | 57% | 0.359 |
BMI (kg/m2) | 29±6 | 28±7 | 0.243 |
Insurance | |||
Medicare Only | 14% | 13% | 0.862 |
Medicaid Only | 3% | 2% | 0.803 |
Did Not Complete High School | 2% | 7% | 0.001* |
Disability Income | 43% | 42% | 0.734 |
Comorbidities | |||
Hypertension | 92% | 90% | 0.386 |
Diabetes | 34% | 36% | 0.608 |
Heart Disease | 18% | 27% | 0.015* |
CVA | 7% | 12% | 0.036* |
Cardiac Catheterization | 11% | 12% | 0.577 |
CABG | 5% | 9% | 0.050* |
Acute MI | 5% | 4% | 0.792 |
CHF | 5% | 5% | 0.818 |
Dialysis History | 0.594 | ||
Preemptive | 23% | 18% | 0.203* |
Peritoneal Dialysis | 15% | 15% | 0.883 |
Hemodialysis | 62% | 67% | 0.355 |
Previous Renal Transplant | 9% | 14% | 0.063* |
HLA Mismatches | 4.2±1.5 | 4.4±1.4 | 0.179* |
PRA | 17±30 | 17±29 | 0.959 |
Cold Ischemic Time (hours) | 16±10 | 16±10 | 0.813 |
Donor ECD | 13% | 13% | 0.947 |
Estimated KDRI | 1.12±0.39 | 1.14±0.42 | 0.625 |
Cytolytic Induction | 43% | 49% | 0.183* |
Delayed Graft Function | 12% | 22% | 0.002* |
Included in the multivariate static and dynamic modeling (p≤0.2)
CVA – Cerebral Vascular Accident, CABG - Coronary Artery Bypass Grafting, MI – Myocardial Infarction, CHF – Congestive Heart Failure, HLA – Human Leukocyte Antigen, PRA – Panel Reactive Antibody, CIT – Cold Ischemia Time, ECD – Expanded Criteria Donor, KDRI – Kidney Donor Risk Index, SBP – Systolic Blood Pressure, PP – Pulse Pressure, SrCr – Serum Creatinine